Chemoinformaics analysis of 2-Methyl-oct-2-enedial
| Molecular Weight | 154.209 | nRot | 6 |
| Heavy Atom Molecular Weight | 140.097 | nRig | 3 |
| Exact Molecular Weight | 154.099 | nRing | 0 |
| Solubility: LogS | -1.399 | nHRing | 0 |
| Solubility: LogP | 0.647 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 25 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 25.9691 |
| nHD | 0 | BPOL | 15.7809 |
| QED | 0.332 |
| Synth | 2.978 |
| Natural Product Likeliness | 2.597 |
| NR-PPAR-gamma | 0.062 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.028 |
| Pgp-sub | 0.002 |
| HIA | 0.011 |
| CACO-2 | -4.524 |
| MDCK | 0.0000221 |
| BBB | 0.992 |
| PPB | 0.379257 |
| VDSS | 0.986 |
| FU | 0.696824 |
| CYP1A2-inh | 0.17 |
| CYP1A2-sub | 0.758 |
| CYP2c19-inh | 0.091 |
| CYP2c19-sub | 0.572 |
| CYP2c9-inh | 0.023 |
| CYP2c9-sub | 0.932 |
| CYP2d6-inh | 0.016 |
| CYP2d6-sub | 0.739 |
| CYP3a4-inh | 0.023 |
| CYP3a4-sub | 0.152 |
| CL | 5.73 |
| T12 | 0.83 |
| hERG | 0.011 |
| Ames | 0.941 |
| ROA | 0.025 |
| SkinSen | 0.965 |
| Carcinogencity | 0.049 |
| EI | 0.993 |
| Respiratory | 0.973 |
| NR-Aromatase | 0.079 |
| Antiviral | No |
| Prediction | 0.952581 |